EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces an agreement with Shenzhen Microprofit Biotech Co., Ltd. to become the exclusive U.S. distributor of ...
Company to submit the ISO 13485 and CE Mark certified fluorecare® test kit under FDA’s EAU and 510(k) clearance for U.S. commercial use fluorecare® SARS-CoV-2 IgG & IgM Antibody Combined Test Kit ...
* NOVABAY PHARMACEUTICALS - TO SUBMIT ISO 13485 AND CE MARK CERTIFIED FLUORECARE TEST KIT UNDER FDA'S EAU AND 510 CLEARANCE FOR U.S. COMMERCIAL USE Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback